Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Deal Origination Executive Search For Sales Teams Corporate Development For Founders For Agencies For Investors Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Start Free
Diagonal Bio logo — Pathogen diagnostics with unprecedented speed, accuracy and...

Diagonal Bio

Pathogen diagnostics with unprecedented speed, accuracy and ease

Founded 2020 Sweden Sweden 10 employees Biotechnology, Health Care

General Information

Company Name Diagonal Bio
Founded Year 2020
Location Sweden Sweden +1
Employees 10
Industries Biotechnology, Health Care
Social

Get notified when Diagonal Bio moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About Diagonal Bio

Diagonal Bio is a dynamic and innovative company that develops a groundbreaking platform technology for ultra-fast, easy-to-use, and accurate detection of genetic markers. The company, founded in 2020 at the onset of the Covid-19 pandemic, aims to revolutionize the diagnosis of infectious diseases. Diagonal Bio’s team is led by experienced professionals in the biotechnology field, including COB Kerstin Jakobsson, interim CEO Karin Wehlin, CFO Per Heander, and a diverse board of directors. The company's operations are based in Lund, Sweden, and its scientific advisors include Prof. Vicent Pelechano (Karolinska Institute, Sweden), Prof. Christelle Prinz (Lund University, Sweden), Prof. Patrik Medstrand (Lund University), Prof. Tautgirdas Ruzgas (Malmö University, Sweden), and Kushagr Punyani (Spermosens AB). Diagonal Bio specializes in the Biotechnology and Health Care industries and can be explored further at www.diagonalbio.com.

Taxonomy: pathogen diagnostics, genetic markers detection, infectious diseases, rapid testing, diagnostic technology, biotech innovation, scientific advisory, platform technology, biomedical research, molecular diagnostics, disease detection

No funding data available for Diagonal Bio yet.

Get notified when Diagonal Bio raises funding

Diagonal Bio Alternatives & Competitors

Diagonal Bio vs
LU Innovation
LU Innovation Sweden

The hub for innovation at Lund University. We work with researchers and students to bring benefit an...

16 employees
Education, Government and Military
Diagonal Bio vs
BiBBInstruments AB
BiBBInstruments AB

EndoDrill® biopsy instruments for early and accurate cancer diagnostics.

Series Unknown
12 employees
Health Care, Medical Devices
Diagonal Bio vs
CombiGene
CombiGene Sweden

CombiGene’s business concept is to develop effective gene therapies for treatment of difficult-to-tr...

Post Ipo Equity
13 employees
Biotechnology, Health and Wellness

FAQ About Diagonal Bio

Pathogen diagnostics with unprecedented speed, accuracy and ease
Diagonal Bio was founded in 2020.
Diagonal Bio is headquartered in Sweden.
Diagonal Bio operates in the following industries: Biotechnology, Health Care.
Diagonal Bio has approximately 10 employees.
Top alternatives and competitors to Diagonal Bio include LU Innovation, BiBBInstruments AB, CombiGene, dLab, Conveneer. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Diagonal Bio and LU Innovation are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors Diagonal Bio and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

Start Tracking — Free

One analytics cookie (Google Analytics). Cookie Policy